Nanoscale composites improve MRI: Researchers merge magnetic particles to detect, fight disease

Jun 16, 2014 by Mike Williams
Silicon mesoporous particles, aka SiMPS, about 1,000 nanometers across contain thousands of much smaller particles of iron oxide. The SiMPs can be manipulated by magnets and gather at the site of tumors, where they can be heated to kill malignant tumors or trigger the release of drugs. The particles were created by an international team led by scientists at Rice University and The Methodist Hospital Research Institute in Houston. Credit: The Wilson Group

(Phys.org) —Submicroscopic particles that contain even smaller particles of iron oxide could make magnetic resonance imaging (MRI) a far more powerful tool to detect and fight disease.

Scientists at Rice University and The Methodist Hospital Research Institute (TMHRI) led an international team of researchers in creating composite particles that can be injected into patients and guided by magnetic fields. Once in position, the particles may be heated to kill malignant tissues or trigger the release of drugs at the site.

The "nanoconstructs" should fully degrade and leave the body within a few days, they reported.

The research appears online in the journal Advanced Functional Materials.

The team led by Rice chemist Lon Wilson and TMHRI scientist Paolo Decuzzi was searching for a way to overcome the challenges presented by iron oxide particles that are good at some things but not others, depending on their size.

Iron oxide particles have many excellent qualities: They can be manipulated with magnets, provide excellent contrast under MRI, create heat when triggered and degrade quickly. But they can't do all that at once. The team needed a way to decouple the functions from their sizes.

The answer was to package thousands of iron oxide particles – with magnetic cores as small as 5 nanometers across – inside larger particles.

Nanoconstructs that contain iron oxide particles could make magnetic resonance imaging a far more powerful tool to detect and fight disease. Credit: Ayrat Gizzatov

The researchers made two such nanoconstructs, embedding iron oxide particles in silicon mesoporous particles (SiMPs) and discoidal polymeric nanoconstructs (DPNs). They knew from previous research that submicron-sized SiMPs and DPNs naturally accumulate within the tumor's blood vessels.

Iron oxide enhances the ability to position and hold the particles in place with magnets, said lead author and Rice graduate student Ayrat Gizzatov. "They get attracted by the magnet, and that induces another dipole-dipole magnetic interaction among the particles and increases their interparticle communication mechanism," he said.

Tests showed iron made the nanoconstructs 10 times better than traditional contrast agents with what amounted to significantly lower doses of iron than used in current practice.

The new research also showed that, as a general principle, confining MRI contrast agents (like ) in geometric structures enhances their relaxivity – the property that makes the agents appear in MRI images. (The shorter the relaxation time, the greater the contrast in the image.)

While the particles are too big to target specific proteins, Gizzatov said it might also be possible to modify them with elements that will increase their accumulation in tumors.

Explore further: Nanoparticles on track to distinguish tumour tissue

More information: Gizzatov, A., Key, J., Aryal, S., Ananta, J., Cervadoro, A., Palange, A. L., Fasano, M., Stigliano, C., Zhong, M., Di Mascolo, D., Guven, A., Chiavazzo, E., Asinari, P., Liu, X., Ferrari, M., Wilson, L. J. and Decuzzi, P. (2014), "Hierarchically Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor Accumulation." Adv. Funct. Mater.. doi: 10.1002/adfm.201400653

add to favorites email to friend print save as pdf

Related Stories

New nanoparticle delivers, tracks cancer drugs

Oct 29, 2013

(Phys.org) —UNSW chemical engineers have synthesised a new iron oxide nanoparticle that delivers cancer drugs to cells while simultaneously monitoring the drug release in real time.

Labeling Cells with Magnetic Nanoparticles

Feb 20, 2007

Investigators at the German Cancer Research Center have developed silica-coated iron oxide nanoparticles that allow for cell tracking in a live animal using magnetic resonance imaging (MRI). More sensitive methods for tracking ...

Recommended for you

Nanosafety research: The quest for the gold standard

Oct 29, 2014

Empa toxicologist Harald Krug has lambasted his colleagues in the journal Angewandte Chemie. He evaluated several thousand studies on the risks associated with nanoparticles and discovered no end of shortc ...

New nanodevice to improve cancer treatment monitoring

Oct 27, 2014

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten ...

Molecular beacons shine light on how cells 'crawl'

Oct 24, 2014

Adherent cells, the kind that form the architecture of all multi-cellular organisms, are mechanically engineered with precise forces that allow them to move around and stick to things. Proteins called integrin ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.